FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy

doi:10.3748/wjg.v20.i30.10316

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9194)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

667

WORD

270

HTML

5578

Figures (1-1)

144

Tables (1-3)

122

Sum=6781

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1506

Download

907

Sum=2413

Aug 14, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 14, 2014; 20(30): 10316-10330
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10316

Open in New Tab Full Size Figure Download Figure

Figure 1 Chemical structures of components of 5-fluorouracil/leucovorin combined with oxaliplatin and irinotecan regimens.

Citation: Mohelnikova-Duchonova B, Melichar B, Soucek P. FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy. World J Gastroenterol 2014; 20(30): 10316-10330
URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10316.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10316